European Case Law Identifier: | ECLI:EP:BA:2003:T048601.20030903 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 03 September 2003 | ||||||||
Case number: | T 0486/01 | ||||||||
Application number: | 92917908.3 | ||||||||
IPC class: | A61K 38/30 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | IGF-1 to improve the neural condition | ||||||||
Applicant name: | GENENTECH, INC., et al | ||||||||
Opponent name: | Cephalon, Inc. | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Main request and auxiliary request 1 - novelty (no) - further medical use (no) Auxiliary requests 2 and 3 - inventive step (no) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t010486eu1.html
Date retrieved: 17 May 2021
11 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.Case Law Book: I Patentability
XCLR I C 7.2.4.I Discovery of a previously unknown property of a compound underlying the known effect